{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:47:32Z","timestamp":1768891652008,"version":"3.49.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.gtc.2011.06.008","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T03:17:01Z","timestamp":1315365421000},"page":"611-639","source":"Crossref","is-referenced-by-count":32,"title":["Alcoholic Hepatitis: Prognostic Models and Treatment"],"prefix":"10.1016","volume":"40","author":[{"given":"Ashwani K.","family":"Singal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2011.06.008_bib1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","author":"Naveau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology","volume":"93","author":"McCullough","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2036.2007.03369.x","article-title":"Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease","volume":"26","author":"Tripodi","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.06.008_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib9","series-title":"Surgery and portal hypertension","author":"Child","year":"1964"},{"key":"10.1016\/j.gtc.2011.06.008_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0168-8278(04)00064-9","article-title":"Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease","volume":"40","author":"Said","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib12","first-page":"93","article-title":"[Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis]","volume":"49","author":"Jeong","year":"2007","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4065\/mcp.2010.0281","article-title":"Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis","volume":"86","author":"Vaa","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2011.06.008_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jlts.2003.50031","article-title":"Is the change in MELD score a better indicator of mortality than baseline MELD score?","volume":"9","author":"Kamath","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10620-006-9099-z","article-title":"Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events","volume":"51","author":"Verma","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.06.008_bib20","first-page":"57","article-title":"[do MELD or Maddrey?","volume":"73","author":"Zapata-Irrison","year":"2008","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.gtc.2011.06.008_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib22","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.06.008_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.06.008_bib24","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2011.06.008_bib26","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(10)60085-2","article-title":"Treatment of severe acute alcoholic hepatitis (AAH) with corticoids plus N-acetylcysteine (C+NAC) versus corticoids alone (C): a multicenter, randomized, controlled trial","volume":"52","author":"Nguyen-Khac","year":"2010","journal-title":"J Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib27","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"4 Suppl","key":"10.1016\/j.gtc.2011.06.008_bib28","first-page":"1109A","article-title":"A response guided therapy for a better management of patients with severe alcoholic hepatitis treated with corticosteroids","volume":"52","author":"Louvet","year":"2010","journal-title":"Hepatology"},{"issue":"4 Suppl","key":"10.1016\/j.gtc.2011.06.008_bib29","first-page":"346A","article-title":"Treatment of severe acute alcoholic hepatitis (AAH) with corticoids plus N-acetylcysteine (C+NAC) versus corticoids alone (C): a multicenter, randomized, controlled trial","volume":"50","author":"Nguyen-Khac","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2011.06.008_bib30","first-page":"S13","article-title":"Early transplantation improves survival of non-responders to steroids in severe alcoholic hepatitis: a challenge to the 6-month rule of abstinence","volume":"52","author":"Castel","year":"2009","journal-title":"J Hepatology"},{"issue":"4 Suppl","key":"10.1016\/j.gtc.2011.06.008_bib31","first-page":"1108A","article-title":"Prognostic scores are efficient in patients with severe alcoholic hepatitis treated with corticosteroids: comparison of available models","volume":"52","author":"Louvet","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","article-title":"Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis","volume":"23","author":"Pessione","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.gtc.2011.06.008_bib33","first-page":"335","article-title":"The prognosis and outcome of alcoholic liver disease","volume":"2","author":"Morgan","year":"1994","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1016\/j.gtc.2011.06.008_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpediatrics.2009.235","article-title":"Interventions for reducing adolescent alcohol abuse: a meta-analytic review","volume":"164","author":"Tripodi","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/0-306-48626-1_1","article-title":"Diagnosis, course, and assessment of alcohol abuse and dependence in adolescents","volume":"17","author":"Chung","year":"2005","journal-title":"Recent Dev Alcohol"},{"key":"10.1016\/j.gtc.2011.06.008_bib36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.gtc.2011.06.008_bib37","article-title":"Acamprosate for alcohol dependence","volume":"9","author":"Rosner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2011.06.008_bib38","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2011.06.008_bib39","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2009.191","article-title":"Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program","volume":"104","author":"Garcia-Tsao","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","article-title":"Protein-calorie malnutrition associated with alcoholic hepatitis","volume":"76","author":"Mendenhall","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cld.2004.11.003","article-title":"Nutritional aspects of alcoholic liver disease","volume":"9","author":"Leevy","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gtc.2011.06.008_bib42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/0148607195019004258","article-title":"Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment","volume":"19","author":"Mendenhall","year":"1995","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.gtc.2011.06.008_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabr\u00e9","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/07315724.1995.10718487","article-title":"Protein consumption and hepatic encephalopathy in alcoholic hepatitis","volume":"14","author":"Morgan","year":"1995","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.gtc.2011.06.008_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","article-title":"ESPEN Guidelines on Enteral Nutrition: Liver disease","volume":"25","author":"Plauth","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.gtc.2011.06.008_bib47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Alcoholic hepatitis","volume":"74","author":"Helman","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib48","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197106172842404","article-title":"Corticosteroid therapy in severe alcoholic hepatitis","volume":"284","author":"Porter","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":"Prednisone therapy of acute alcoholic hepatitis","volume":"79","author":"Campra","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01072499","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis","volume":"22","author":"Blitzer","year":"1977","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.gtc.2011.06.008_bib51","first-page":"443","article-title":"A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis","volume":"69","author":"Shumaker","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.06.008_bib55","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med 20"},{"key":"10.1016\/j.gtc.2011.06.008_bib57","first-page":"223","article-title":"[Corticoid therapy in the treatment of acute alcoholic hepatitis. Results of a meta-analysis]","volume":"15","author":"Daures","year":"1991","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gtc.2011.06.008_bib58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis?","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.06.008_bib60","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0168-8278(01)00190-8","article-title":"Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood","volume":"35","author":"Spahr","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib61","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0168-8278(00)80219-6","article-title":"Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids","volume":"32","author":"Taieb","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib62","first-page":"S75","article-title":"Influence of corticosteroids (CS) on plasma cytokines concentrations in patients with severe alcoholic hepatitis (HA): results of a randomized study","volume":"18","author":"Richardet","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib63","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib64","doi-asserted-by":"crossref","unstructured":"Kendrick SF, Henderson E, Palmer J, et al. Theophylline improves steroid sensitivity in acute alcoholic hepatitis. Hepatology;52:126\u201331.","DOI":"10.1002\/hep.23666"},{"key":"10.1016\/j.gtc.2011.06.008_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib66","first-page":"G847","article-title":"Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNF-alpha release","volume":"277","author":"Reuter","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.gtc.2011.06.008_bib67","first-page":"96A","article-title":"Pentoxifylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepatitis","volume":"14","author":"McHutchison","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib68","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib69","first-page":"A459","article-title":"Role of pentoxifylline in treatment of severe acute alcoholic hepatitis\u2014a randomized controlled trial","volume":"21","author":"Paladugu","year":"2006","journal-title":"J Gastrenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib70","first-page":"A373","article-title":"Pentoxifyline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: a double blind, placebo controlled trial","volume":"44","author":"Sidhu","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib71","first-page":"A249","article-title":"Pentoxifylline for the treatment of patients with advanced cirrhosis","volume":"46","author":"Lebrec","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib72","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial","volume":"15","author":"De","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib74","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1053\/gast.2000.20826","article-title":"Pentoxifylline and alcoholic hepatitis","volume":"119","author":"Morgan","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib75","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/SLA.0b013e3181fcbc5e","article-title":"Effects of pentoxifylline on liver regeneration: a double-blinded, randomized, controlled trial in 101 patients undergoing major liver resection","volume":"252","author":"Petrowsky","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.gtc.2011.06.008_bib76","doi-asserted-by":"crossref","unstructured":"Lebrec D, Thabut D, Oberti F, et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology;138:1755\u201362.","DOI":"10.1053\/j.gastro.2010.01.040"},{"issue":"10 Suppl","key":"10.1016\/j.gtc.2011.06.008_bib77","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1097\/00003246-199310001-00006","article-title":"Role of tumor necrosis factor-alpha in disease states and inflammation","volume":"21","author":"Strieter","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib78","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.510260621","article-title":"Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat","volume":"26","author":"Iimuro","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib79","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib80","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","article-title":"Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial","volume":"50","author":"Sharma","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib81","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib82","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.06.008_bib84","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib85","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1073\/pnas.94.4.1441","article-title":"Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor","volume":"94","author":"Yamada","year":"1997","journal-title":"Proc Natl Acad Sci U S A 18"},{"key":"10.1016\/j.gtc.2011.06.008_bib86","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q","article-title":"TNF-alpha gene polymorphism: clinical and biological implications","volume":"50","author":"Hajeer","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.gtc.2011.06.008_bib87","first-page":"1577","article-title":"Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor","volume":"152","author":"Yamada","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gtc.2011.06.008_bib88","first-page":"G579","article-title":"Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy","volume":"263","author":"Akerman","year":"1992","journal-title":"Am J Physiol"},{"issue":"2 Suppl 1","key":"10.1016\/j.gtc.2011.06.008_bib89","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/hep.20957","article-title":"Alcohol and oxidative liver injury","volume":"43","author":"Dey","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-5849(02)01167-X","article-title":"Oxidative stress in viral and alcoholic hepatitis","volume":"34","author":"Loguercio","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib91","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2014a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib92","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib93","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib94","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib95","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF03160941","article-title":"Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management","volume":"4","author":"Mazer","year":"2008","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.gtc.2011.06.008_bib96","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.gtc.2011.06.008_bib97","first-page":"346A","article-title":"Treatment of severe acute alcoholic hepatitis (AAH) with corticoids plus N-acetylcysteine (C+NAC) versus corticoids alone (C): a multicenter randomized controlled trial [abstract]","volume":"50","author":"Ngyen-Khac","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(84)92109-3","article-title":"The leaky gut of alcoholism: possible route of entry for toxic compounds","volume":"1","author":"Bjarnason","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2011.06.008_bib99","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2009.03.007","article-title":"Signalling pathways in alcohol-induced liver inflammation","volume":"50","author":"Mandrekar","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib100","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1443-9573.2004.00157.x","article-title":"Intestinal microflora in patients with liver cirrhosis","volume":"5","author":"Zhao","year":"2004","journal-title":"Chin J Dig Dis"},{"key":"10.1016\/j.gtc.2011.06.008_bib102","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.gtc.2011.06.008_bib103","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00003495-199549030-00009","article-title":"Rifaximin","volume":"49","author":"Gillis","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.gtc.2011.06.008_bib105","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2036.2009.03958.x","article-title":"Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis","volume":"29","author":"Vlachogiannakos","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.06.008_bib106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib107","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2011.06.008_bib108","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0168-8278(88)80005-9","article-title":"Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis","volume":"28","author":"Bird","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib109","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.1840140624","article-title":"Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial","volume":"14","author":"Mezey","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib110","first-page":"551","article-title":"Treatment of alcoholic hepatitis with colchicine","volume":"13","author":"Trinchet","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gtc.2011.06.008_bib111","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003620","article-title":"Propylthiouracil for alcoholic liver disease","volume":"2","author":"Rambaldi","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2011.06.008_bib113","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10620-006-8038-3","article-title":"Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation","volume":"51","author":"Samara","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.06.008_bib114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0741-8329(02)00200-8","article-title":"Neutrophil-mediated tissue injury in alcoholic hepatitis","volume":"27","author":"Jaeschke","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.gtc.2011.06.008_bib115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MEG.0b013e328332a360","article-title":"Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series","volume":"22","author":"Morris","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib116","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","article-title":"Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis","volume":"38","author":"Jalan","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib118","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2005.01.032","article-title":"Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis","volume":"43","author":"Sen","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib119","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0300-483X(95)03128-3","article-title":"Recombinant human interleukin-6: safety issues of a pleiotropic growth factor","volume":"105","author":"Kammuller","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.gtc.2011.06.008_bib120","doi-asserted-by":"crossref","unstructured":"Ki SH, Park O, Zheng M, et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology Oct;52:1291\u2013300.","DOI":"10.1002\/hep.23837"},{"key":"10.1016\/j.gtc.2011.06.008_bib121","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2006.04.013","article-title":"Intrahepatic gene expression in human alcoholic hepatitis","volume":"45","author":"Seth","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib122","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.06.008_bib123","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","article-title":"Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity","volume":"132","author":"Colmenero","year":"2007","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2011.06.008_bib124","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0168-8278(10)60051-7","article-title":"Osteopontin is a novel therapeutic target in patients with alcoholic hepatitis","volume":"52","author":"Morales","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.23663","article-title":"Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells","volume":"52","author":"Tirnitz-Parker","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.gtc.2011.06.008_bib126","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007339.pub2","article-title":"Pentoxifylline for alcoholic hepatitis","volume":"4","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2011.06.008_bib127","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/lt.500030313","article-title":"Relapse after transplantation: European studies","volume":"3","author":"Neuberger","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.gtc.2011.06.008_bib128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/bmj.317.7152.172","article-title":"Assessing priorities for allocation of donor liver grafts: survey of public and clinicians","volume":"317","author":"Neuberger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.gtc.2011.06.008_bib129","series-title":"Liver transplantation for alcoholic liver disease","author":"Anantharaju","year":"2004"},{"key":"10.1016\/j.gtc.2011.06.008_bib130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/jlts.2001.23789","article-title":"Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism","volume":"7","author":"Mackie","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/alcalc\/agl033","article-title":"Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria","volume":"41","author":"McCallum","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.gtc.2011.06.008_bib132","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/jlts.2000.18497","article-title":"Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery","volume":"6","author":"Weinrieb","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib133","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/lt.20934","article-title":"Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease","volume":"13","author":"Pfitzmann","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib134","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/lt.500030613","article-title":"Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases","volume":"3","author":"Lucey","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"11 Suppl 2","key":"10.1016\/j.gtc.2011.06.008_bib135","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/lt.20601","article-title":"Is alcoholic hepatitis an indication for transplantation?","author":"Mathurin","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib136","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2009.12.021","article-title":"The place of liver transplantation in the treatment of severe alcoholic hepatitis","volume":"52","author":"Dureja","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib137","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/lt.20688","article-title":"Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease","volume":"12","author":"DiMartini","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib138","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0168-8278(02)00047-8","article-title":"Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease","volume":"36","author":"Tome","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gtc.2011.06.008_bib139","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/lt.21298","article-title":"The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation","volume":"13","author":"Wells","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gtc.2011.06.008_bib140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/jlts.1997.v3.ajlts0030240","article-title":"Survival and quality of life after liver transplantation for acute alcoholic hepatitis","volume":"3","author":"Shakil","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.gtc.2011.06.008_bib141","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.transproceed.2009.03.092","article-title":"Alcohol abstinence and orthotopic liver transplantation in alcoholic liver cirrhosis","volume":"41","author":"Immordino","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.gtc.2011.06.008_bib142","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/0003-4819-150-3-200902030-00004","article-title":"Immediate listing for liver transplantation versus standard care for Child-Pugh stage B AC: a randomized trial","volume":"150","author":"Vanlemmens","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855311000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855311000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T21:56:19Z","timestamp":1560549379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855311000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":142,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0889855311000604"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2011.06.008","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}